Susanna Curtis
Icahn School of Medicine at Mount Sinai · MOUNT SINAI HOSPITAL · Yale University School of Medicine Oncology Section
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Susanna Curtis as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:34 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06930703 · Cannabidiol in Sickle Cell DiseaseIcahn School of Medicine at Mount Sinai · recruiting · Sickle Cell Disease · principal investigator
- Ph2NCT05519111 · Cannabinoids for the Reduction of Inflammation and Sickle Cell Related PainIcahn School of Medicine at Mount Sinai · recruiting · Sickle Cell Disease · principal investigator
- Ph1NCT03978156 · Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell DiseaseYale University · terminated · Sickle Cell Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Inflammatory Biosignatures for the Identification of Sickle Cell Associated Pain Phenotypes (IBIS-CAP)R01HL183340 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2026 · $834,899 awarded in 2026Same name and institution; not confirmed by an ID
- Dronabinol for the reduction of chronic pain and inflammation in people with sickle cell diseaseK23HL151884 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2021 to 2025 · $193,276 awarded in 2025Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:34 UTC. The ranking covers the 200 most relevant of 55 PubMed records, and a shared surname and initials can bring in a namesake. All 55 on PubMed
- Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence.Stroke · 1995274 citationsRCR 9.2
- A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis.Arthritis Rheumatol · 2015187 citationsRCR 7.8
- A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia.Stroke · 2001160 citationsRCR 4.7
- Music to reduce pain and distress in the pediatric emergency department: a randomized clinical trial.JAMA Pediatr · 2013101 citationsRCR 5.2
- A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.J Rheumatol · 2002100 citationsRCR 2.8
- Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.Rheumatology (Oxford) · 200295 citationsRCR 2.9
- Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac.Gastroenterology · 200888 citationsRCR 2.8
- How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial.Am J Gastroenterol · 200982 citationsRCR 2.9
- Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: a prospective, multicenter study.Crit Care Med · 199373 citationsRCR 2.8
- The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure.Eur Heart J · 199873 citationsRCR 2.5